Please assess the completion status of the following clinical trial:

Trial Title: Sodium Bicarbonate and N-Acetylcysteine for Nephroprotection in Acute Myocardial Infarction

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: None
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* ST-Segment Elevation Myocardial Infarction (STEMI) as diagnosed according to the ACC (American College of Cardiology) criteria:~* ischemic symptoms;~* ECG variations: ST-elevation (\>0,05 mV) in two or more contiguous leads;~* Increase of the biochemical markers of myocardial necrosis (troponin T, cTNT). • Indication to urgent coronary angiography and primary or rescue PCI~Exclusion Criteria:~* Patients with history of allergic reaction to NAC~* Chronic hemodialysis~* Age \>= 90 years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Study Arms:
- Sodium bicarbonate plus NAC (Type: None): Sodium bicarbonate plus NAC
- Saline hydration plus NAC (Type: None): Saline hydration plus NAC

Based on this trial design, predict the completion outcome and termination type (if applicable).